Elevated Pre-Treatment Systemic Immuno-Inflammatory Indices, Triple-Negative Breast Cancer, and p53 Mutation are Associated with Early-Onset Breast Cancer in Southern Nigeria

Jude Ogechukwu Okoye, Dorcas Onyeka Samuel, Kosisochukwu Stephanie Ezidiegwu, Michael Emeka Chiemeka
doi: https://doi.org/10.1101/2023.11.09.23298295

Article Information

doi 
https://doi.org/10.1101/2023.11.09.23298295
History 
  • November 10, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Jude Ogechukwu Okoye*,1,
  2. Dorcas Onyeka Samuel1,
  3. Kosisochukwu Stephanie Ezidiegwu1 and
  4. Michael Emeka Chiemeka2
  1. 1Department of Medical Laboratory Science, Faculty of Health Science and Technology, College of Health Sciences, Nnamdi Azikiwe University, Nnewi, Nigeria
  2. 2Department of Morbid Anatomy and Forensic Medicine, Nnamdi Azikiwe University Teaching Hospital (NAUTH), Nnewi, Nigeria
  1. ↵*Correspondence Author:
    Okoye, J.O. E-mail: jog.okoye{at}unizik.edu.ng; +2347031119994
Back to top
Posted November 10, 2023.
Download PDF
Data/Code
Email
Elevated Pre-Treatment Systemic Immuno-Inflammatory Indices, Triple-Negative Breast Cancer, and p53 Mutation are Associated with Early-Onset Breast Cancer in Southern Nigeria
Jude Ogechukwu Okoye, Dorcas Onyeka Samuel, Kosisochukwu Stephanie Ezidiegwu, Michael Emeka Chiemeka
medRxiv 2023.11.09.23298295; doi: https://doi.org/10.1101/2023.11.09.23298295
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area